Inventor · disambiguated record
Roger Crystal
Also filed as: CRYSTAL ROGER
10 granted patents·23 pending applications·135 citations·filing 2015–2024
91Inventor score
Files withOPIANT PHARMACEUTICALS INC11ADAPT PHARMA LTD9LIGHTLAKE THERAPEUTICS INC4AEGIS THERAPEUTICS LLC3INDIVIOR INC2
Top patents by PatentIndex Score
33 records- 0195US9707226B2Nasal drug products and methods of their useADAPT PHARMA LTD·Filed 2017·Granted Jul 18, 2017·16 cites·101 claims
- 0295US9629965B2Nasal drug products and methods of their useOPIANT PHARMACEUTICALS INC·Filed 2016·Granted Apr 25, 2017·18 cites·30 claims
- 0395US9480644B2Nasal drug products and methods of their useLIGHTLAKE THERAPEUTICS INC·Filed 2015·Granted Nov 1, 2016·20 cites·69 claims
- 0494US9775838B2Nasal drug products and methods of their useADAPT PHARMA LTD·Filed 2017·Granted Oct 3, 2017·10 cites·46 claims
- 0593US9561177B2Nasal drug products and methods of their useADAPT PHARMA LTD·Filed 2016·Granted Feb 7, 2017·19 cites·30 claims
- 0693US9468747B2Nasal drug products and methods of their useLIGHTLAKE THERAPEUTICS INC·Filed 2015·Granted Oct 18, 2016·18 cites·45 claims
- 0793US9211253B2Nasal drug products and methods of their useLIGHTLAKE THERAPEUTICS INC·Filed 2015·Granted Dec 15, 2015·25 cites·29 claims
- 0888US10085937B2Nasal drug products and methods of their useADAPT PHARMA LTD·Filed 2016·Granted Oct 2, 2018·7 cites·34 claims
- 0986US11458091B2Compositions and methods for the treatment of opioid overdoseOPIANT PHARMACEUTICALS INC·Filed 2017·Granted Oct 4, 2022·2 cites·15 claims
- 1075US2022071896A1Nasal drug products and methods of their useADAPT PHARMA LTD·Filed 2021·Application pending·0 cites
- 1175US2023225961A1Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid OverdoseOPIANT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1274US2020030229A1Nasal drug products and methods of their useADAPT PHARMA LTD·Filed 2019·Application pending·0 cites
- 1373US2024197719A1Formulations and methods for the prevention of opioid overdoseAEGIS THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 1473US2025127712A1Compositions and methods for the treatment of opioid overdoseINDIVIOR INC·Filed 2024·Application pending·0 cites
- 1571US2022387306A1Compositions and methods for the treatment of opioid overdoseOPIANT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1670US2021275519A1Nasal drug products and methods of their useOPIANT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1769US2021401827A1Methods, parenteral pharmaceutical formulations, and devices for the prevention of opioid overdoseOPIANT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1867US2021093557A1Nasal drug products and methods of their useADAPT PHARMA LTD·Filed 2020·Application pending·0 cites
- 1967US2021275444A1Methods, parenteral pharmaceutical formulations, and devices for the prevention of opioid overdoseOPIANT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2065US2017304295A1Nasal drug products and methods of their useOPIANT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2163US2024408004A1Compositions, devices, and methods for the treatment of overdose and reward-based disordersAEGIS THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 2263US2024408003A1Compositions, devices and methods for the treatment of alcohol use disorderINDIVIOR UK LTD·Filed 2023·Application pending·0 cites
- 2360US2021077382A1Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditionsOPIANT PHAMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2460US2019015323A1Nasal drug products and methods of their useADAPT PHARMA LTD·Filed 2018·Application pending·0 cites
- 2558US12290596B2Compositions and methods for the treatment of opioid overdoseINDIVIOR INC·Filed 2022·Granted May 6, 2025·0 cites·2 claims
- 2658US2024307363A1Methods for treating a pulmonary disease with an alk-5 (tgf beta r1) inhibitorTHIRONA BIO INC·Filed 2022·Application pending·0 cites
- 2756US2019262263A1Compositions, devices and methods for the treatment of opioid-receptor-mediated conditionsOPIANT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2854US2018169006A1Co-packaged drug productsOPIANT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2954US2017151230A1Nasal drug products and methods of their useADAPT PHARMA LTD·Filed 2017·Application pending·0 cites
- 3053US2021220346A1Formulations and methods for the prevention of opioid overdoseAEGIS THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 3150US2020390691A1Compositions, devices, and methods for the treatment of overdose and reward-based disordersAEGIS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3240US2016008277A1Co-packaged drug productsLIGHTLAKE THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3339US2019209464A1Compositions, devices and methods for the treatment of alcohol use disorderOPIANT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roger Crystal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →